Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Increased bone fragility attributed to osteopenia is a serious side effect of glucocorticoid treatment. Glucocorticoid‐induced bone loss is caused primarily by hypofunction and apoptosis of osteoblasts, and secondarily by accelerated bone resorption. To explore the mechanism whereby dexamethasone (Dex) stimulates osteoclastogenesis in the coculture system, we analyzed the effect of Dex on the expression of both mouse osteoprotegerin (OPG) and receptor activator of NF‐κB ligand (RANKL). Dex reduced OPG transcripts and OPG protein secretion by the ST2 osteoblastic cells. Since mainly the c‐Jun homodimer maintains the steady‐state transcription of the OPG gene, we examined the effect of Dex on c‐Jun signaling in ST2 cells. Western blotting disclosed that Dex decreased the amount of phospho‐c‐Jun protein (p‐c‐Jun) and, correspondingly, the amount of the phosphorylated p46 isoform of Jun N‐terminal kinase (JNK). The amount of phospho‐SEK1 also decreased after Dex treatment, while the amounts of phospho‐ERK and p38 remained constant. Among mitogen‐activated protein (MAP) kinase inhibitors, the JNK inhibitor mimicked the inhibitory effect of Dex on OPG promoter activity. On the other hand, Dex treatment per se showed a nominal increase of RANKL gene expression. A part of Dex‐mediated OPG gene suppression was achieved by the suppression of β‐catenin signaling. We speculate therefore that the bone resorptive action of Dex is mediated mainly by the inhibition of OPG by transrepressing the OPG gene through the AP‐1 site, with a reduction (mediated mainly by the decrease in the p46 isoform of JNK) in the proportion of p‐c‐Jun in a JNK‐dependent manner. J. Cell. Biochem. 103: 335–345, 2008. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“E-mail: kitazawa@med.kobe-u.ac.jp Received 22 January 2007; Accepted 18 April 2007 DOI 10.1002/jcb.21414 et al., 1997b; Lacey et al., 1998;Nakagawaet al., 1998; Quinn et al., 1998; Yasuda et al., 1998].”
InfluentialOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775 · cited 1×
“…and many of the regulators of bonemetabolismregulate bone volume by modulating osteoclastogenesis through this RANKL–OPG axis [Horwood et al., 1998; Murakami et al., 1998; Takai et al., 1998; Vidal et al., 1998; Brandstrom et al., 1998a,b; Nagai and Sato, 1999; Hofbauer et al., 2000].”
BackgroundRANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., & Higashio, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9788 · Cited by 746
Glucocorticoids suppress bone formation via the osteoclast.
Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384 · cited 2×
“Also, Gr / mice are spared the impact of Dex on osteoclasts and their precursors [Kim et al., 2006].”
BackgroundTakai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299
Cited by
Injectable Corticosteroid and Local Anesthetic Preparations: A Review for Radiologists
MacMahon, P. J., Eustace, S. J., & Kavanagh, E. C. (2009) · Radiology · doi:10.1148/radiol.2523081929 · Cited by 263
Pathogenic mechanisms of glucocorticoid-induced osteoporosis
Chen, M., Fu, W., Xu, H., & Liu, C.-J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.03.002 · Cited by 146
Decker, A., Askar, H., Tattan, M., Taichman, R., & Wang, H.-L. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-019-03089-3 · Cited by 98
Blaschke, M., Koepp, R., Cortis, J., Komrakova, M., Schieker, M., Hempel, U., & Siggelkow, H. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/67561 · Cited by 73
Large-scale analysis of glucocorticoid target genes in rat hypothalamus
Sato, H., Horikawa, Y., Iizuka, K., Sakurai, N., Tanaka, T., Shihara, N., Oshima, A., Takeda, J., & Mikuni, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05489.x · Cited by 46
Mechanism and treatment strategy of osteoporosis after transplantation
Song, L., Xie, X.-B., Peng, L.-K., Yu, S.-J., & Peng, Y.-T. (2015) · International Journal of Endocrinology · doi:10.1155/2015/280164 · Cited by 30
Metadata
- Authors
- Kondo, T., Kitazawa, R., Yamaguchi, A., & Kitazawa, S.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2007-05-21
- Volume
- 103
- Issue
- 1
- Pages
- 335-345
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1971494641
- Cited by
- 103
- References
- 14
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.